Cargando…

Protein-protein interaction networks identify targets which rescue the MPP(+) cellular model of Parkinson’s disease

Neurodegenerative diseases are complex multifactorial disorders characterised by the interplay of many dysregulated physiological processes. As an exemplar, Parkinson’s disease (PD) involves multiple perturbed cellular functions, including mitochondrial dysfunction and autophagic dysregulation in pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keane, Harriet, Ryan, Brent J., Jackson, Brendan, Whitmore, Alan, Wade-Martins, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660280/ https://www.ncbi.nlm.nih.gov/pubmed/26608097 http://dx.doi.org/10.1038/srep17004

Ejemplares similares

Costunolide and Parthenolide Ameliorate MPP+ Induced Apoptosis in the Cellular Parkinson’s Disease Model
por: Arslan, Mehmet Enes, et al.
Publicado: (2023)

Characteristics of the mitochondrial and cellular uptake of MPP(+), as probed by the fluorescent mimic, 4'I-MPP(+)
por: Mapa, Mapa S. T., et al.
Publicado: (2018)

High-Resolution Respirometry Reveals MPP(+) Mitochondrial Toxicity Mechanism in a Cellular Model of Parkinson’s Disease
por: Risiglione, Pierpaolo, et al.
Publicado: (2020)

Efficient GSH delivery using PAMAM-GSH into MPP-induced PC12 cellular model for Parkinson’s disease
por: Sun, Hong-Ji, et al.
Publicado: (2016)

Neuroprotective and Neurorestorative Effects of Holothuria scabra Extract in the MPTP/MPP(+)-Induced Mouse and Cellular Models of Parkinson’s Disease
por: Noonong, Kunwadee, et al.
Publicado: (2020)

Tilianin attenuates MPP(+)-induced oxidative stress and apoptosis of dopaminergic neurons in a cellular model of Parkinson's disease
por: Li, Jie, et al.
Publicado: (2022)

The Alteration of Nasopharyngeal and Oropharyngeal Microbiota in Children with MPP and Non-MPP
por: Lu, Zhiwei, et al.
Publicado: (2017)

Multi-parameter Behavioral Phenotyping of the MPP+ Model of Parkinson’s Disease in Zebrafish
por: Christensen, Christian, et al.
Publicado: (2020)

LINC00667 regulates MPP(+)‐induced neuronal injury in Parkinson’s disease
por: Huo, Xinlong, et al.
Publicado: (2022)

The Neuroprotective Effect of Steroid Receptor Coactivator-Interacting Protein (SIP) in Astrocyte Model of 1-Methyl-4-Phenylpyridinium (MPP(+))-Induced Parkinson’s Disease
por: Qu, Mingwei
Publicado: (2019)

Cracking the code of cellular protein–protein interactions: Alphafold and whole‐cell crosslinking to the rescue
por: Träger, Toni, et al.
Publicado: (2023)

2013 MPP Workshop
por: Jonker, Michael
Publicado: (2014)

High-Level Expression of Palmitoylated MPP1 Recombinant Protein in Mammalian Cells
por: Chytła, Agnieszka, et al.
Publicado: (2021)

Rapamycin reverses ferroptosis by increasing autophagy in MPTP/MPP(+)-induced models of Parkinson’s disease
por: Liu, Tongyu, et al.
Publicado: (2023)

Proceedings of the 2019 MPP Workshop
por: Strachinescu, Sabina-Ioana, et al.
Publicado: (2019)

The microdomain-organizing protein MPP1 is required for insulin-stimulated activation of H-Ras
por: Podkalicka, Joanna, et al.
Publicado: (2018)

Dioscin-Mediated Autophagy Alleviates MPP(+)-Induced Neuronal Degeneration: An In Vitro Parkinson’s Disease Model
por: Azam, Shofiul, et al.
Publicado: (2022)

The Study of Overexpression of Peroxiredoxin-2 Reduces MPP(+)-Induced Toxicity in the Cell Model of Parkinson’s Disease
por: Liu, Menghao, et al.
Publicado: (2023)

The synaptic scaffold protein MPP2 interacts with GABA(A) receptors at the periphery of the postsynaptic density of glutamatergic synapses
por: Schmerl, Bettina, et al.
Publicado: (2022)

Rescue of Transgenic Alzheimer’s Pathophysiology by Polymeric Cellular Prion Protein Antagonists
por: Gunther, Erik C., et al.
Publicado: (2019)

Molecular characterization of direct interactions between MPP1 and flotillins
por: Biernatowska, Agnieszka, et al.
Publicado: (2021)

Systems biology analysis of the proteomic alterations induced by MPP(+), a Parkinson's disease-related mitochondrial toxin
por: Monti, Chiara, et al.
Publicado: (2015)

Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson’s disease
por: Fan, Fei, et al.
Publicado: (2020)

The selective degradation of sirtuins via macroautophagy in the MPP(+) model of Parkinson’s disease is promoted by conserved oxidation sites
por: Baeken, Marius W., et al.
Publicado: (2021)

Quercetin Protects against MPP(+)/MPTP-Induced Dopaminergic Neuron Death in Parkinson's Disease by Inhibiting Ferroptosis
por: Lin, Zhi-Hao, et al.
Publicado: (2022)

Evaluation of the Combination of Metformin and Rapamycin in an MPP(+)-Treated SH-SY5Y Model of Parkinson's Disease
por: Norradee, Chureerat, et al.
Publicado: (2023)

MPP6 is an exosome-associated RNA-binding protein involved in 5.8S rRNA maturation
por: Schilders, Geurt, et al.
Publicado: (2005)

Open Conformation of the Escherichia coli Periplasmic Murein Tripeptide Binding Protein, MppA, at High Resolution
por: Bhatt, Forum, et al.
Publicado: (2018)

Recent Progress on Genetically Modified Animal Models for Membrane Skeletal Proteins: The 4.1 and MPP Families
por: Terada, Nobuo, et al.
Publicado: (2023)

Cholesterol Interaction with the MAGUK Protein Family Member, MPP1, via CRAC and CRAC-Like Motifs: An In Silico Docking Analysis
por: Listowski, Marcin A., et al.
Publicado: (2015)

Programming for hybrid multi/manycore MPP systems
por: Levesque, John, et al.
Publicado: (2014)

Neuroprotective Effects of San-Huang-Xie-Xin-Tang in the MPP(+)/MPTP Models of Parkinson's Disease In Vitro and In Vivo
por: Lo, Yi-Ching, et al.
Publicado: (2012)

Resolvin D1 Attenuates Mpp+-Induced Parkinson Disease via Inhibiting Inflammation in PC12 Cells
por: Xu, Jinyan, et al.
Publicado: (2017)

Bu-Yin-Qian-Zheng Formula Ameliorates MPP(+)-Induced Mitochondrial Dysfunction in Parkinson’s Disease via Parkin
por: Ma, Hao-Jie, et al.
Publicado: (2020)

Calcitriol Alleviates MPP(+)- and MPTP-Induced Parthanatos Through the VDR/PARP1 Pathway in the Model of Parkinson’s Disease
por: Hu, Junjie, et al.
Publicado: (2021)

CHIP protects against MPP(+)/MPTP-induced damage by regulating Drp1 in two models of Parkinson’s disease
por: Hu, Zhengwei, et al.
Publicado: (2021)

Microglia-dependent neuroprotective effects of 4-octyl itaconate against rotenone-and MPP+-induced neurotoxicity in Parkinson’s disease
por: Xia, Ning, et al.
Publicado: (2023)

MPP7 as a Novel Biomarker of Esophageal Cancer: MPP7 Knockdown Inhibits Esophageal Cancer Cell Migration and Invasion
por: Li, Zhaodong, et al.
Publicado: (2022)

Mitochondrial Uncoupling Protein-2 (UCP2) Mediates Leptin Protection Against MPP(+) Toxicity in Neuronal Cells
por: Ho, Philip Wing-Lok, et al.
Publicado: (2009)

Tri-methylation of ATF7IP by G9a/GLP recruits the chromodomain protein MPP8
por: Tsusaka, Takeshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2dn7090g78lh9dmt7kukpln5v9